Intranasal COVID-19 vaccines: From bench to bed
A Alu, L Chen, H Lei, Y Wei, X Tian, X Wei - EBioMedicine, 2022 - thelancet.com
Currently licensed COVID-19 vaccines are all designed for intramuscular (IM) immunization.
However, vaccination today failed to prevent the virus infection through the upper respiratory …
However, vaccination today failed to prevent the virus infection through the upper respiratory …
[HTML][HTML] Novel approaches for vaccine development
MS Gebre, LA Brito, LH Tostanoski, DK Edwards… - Cell, 2021 - cell.com
Vaccines are critical tools for maintaining global health. Traditional vaccine technologies
have been used across a wide range of bacterial and viral pathogens, yet there are a …
have been used across a wide range of bacterial and viral pathogens, yet there are a …
Emerging concepts and technologies in vaccine development
Despite the success of vaccination to greatly mitigate or eliminate threat of diseases caused
by pathogens, there are still known diseases and emerging pathogens for which the …
by pathogens, there are still known diseases and emerging pathogens for which the …
COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology
HJ Han, C Nwagwu, O Anyim, C Ekweremadu… - International …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic which has induced …
syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic which has induced …
Current state and challenges in developing oral vaccines
While vaccination remains the most cost effective strategy for disease prevention,
communicable diseases persist as the second leading cause of death worldwide. There is a …
communicable diseases persist as the second leading cause of death worldwide. There is a …
Platforms for production of protein-based vaccines: from classical to next-generation strategies
R Cid, J Bolívar - Biomolecules, 2021 - mdpi.com
To date, vaccination has become one of the most effective strategies to control and reduce
infectious diseases, preventing millions of deaths worldwide. The earliest vaccines were …
infectious diseases, preventing millions of deaths worldwide. The earliest vaccines were …
Advances in infectious disease vaccine adjuvants
J Fan, S Jin, L Gilmartin, I Toth, WM Hussein… - Vaccines, 2022 - mdpi.com
Vaccines are one of the most significant medical interventions in the fight against infectious
diseases. Since their discovery by Edward Jenner in 1796, vaccines have reduced the …
diseases. Since their discovery by Edward Jenner in 1796, vaccines have reduced the …
The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world
HR Sharpe, C Gilbride, E Allen… - …, 2020 - Wiley Online Library
Summary Since the first World Health Organization notification on 31 December 2019,
coronavirus disease 2019 (COVID‐19), the respiratory disease caused by the coronavirus …
coronavirus disease 2019 (COVID‐19), the respiratory disease caused by the coronavirus …
Functionalizing ferritin nanoparticles for vaccine development
In the last decade, the interest in ferritin-based vaccines has been increasing due to their
safety and immunogenicity. Candidates against a wide range of pathogens are now on …
safety and immunogenicity. Candidates against a wide range of pathogens are now on …
[HTML][HTML] Fungal vaccines, mechanism of actions and immunology: A comprehensive review
S Nami, R Mohammadi, M Vakili, K Khezripour… - Biomedicine & …, 2019 - Elsevier
Fungal infections include a wide range of opportunistic and invasive diseases. Two of four
major fatal diseases in patients with human immunodeficiency virus (HIV) infection are …
major fatal diseases in patients with human immunodeficiency virus (HIV) infection are …